Anticoagulant News and Research

RSS
Study finds under-treatment of RHD in India, Africa

Study finds under-treatment of RHD in India, Africa

ESC launches European Heart Journal: Acute Cardiovascular Care

ESC launches European Heart Journal: Acute Cardiovascular Care

ThromboGenics resubmits ocriplasmin BLA with FDA to treat symptomatic VMA

ThromboGenics resubmits ocriplasmin BLA with FDA to treat symptomatic VMA

Decreasing GPA adherence among COX-2 users increases risk of upper GI complications

Decreasing GPA adherence among COX-2 users increases risk of upper GI complications

Over-the-counter insect bite remedies not very effective

Over-the-counter insect bite remedies not very effective

Black fly's blood-sucking tactics may be used for medical advancement

Black fly's blood-sucking tactics may be used for medical advancement

Mount Sinai researchers present 86 abstracts and plenary sessions at ACC meeting

Mount Sinai researchers present 86 abstracts and plenary sessions at ACC meeting

CRF initiates Harmonizing Outcomes with Revascularization and Stents in AMI II trial

CRF initiates Harmonizing Outcomes with Revascularization and Stents in AMI II trial

Lower dose of thrombolytics can treat moderate pulmonary embolism

Lower dose of thrombolytics can treat moderate pulmonary embolism

Rivaroxaban found safe and effective in pulmonary embolism

Rivaroxaban found safe and effective in pulmonary embolism

High-risk, high-cost PCI patients can be identified through pre-procedure bleeding risk score

High-risk, high-cost PCI patients can be identified through pre-procedure bleeding risk score

Minimally invasive treatments re-establish blood flow in people with chronic DVT

Minimally invasive treatments re-establish blood flow in people with chronic DVT

Rivaroxaban safer, effective than standard therapy in treating PE

Rivaroxaban safer, effective than standard therapy in treating PE

Study clarifies conflicting reports for clot aspiration and abciximab administration

Study clarifies conflicting reports for clot aspiration and abciximab administration

Bolus intracoronary abciximab reduces infarct size in high-risk patients with STEMI

Bolus intracoronary abciximab reduces infarct size in high-risk patients with STEMI

ThromboGenics, Alcon collaborate to commercialize ocriplasmin outside the US

ThromboGenics, Alcon collaborate to commercialize ocriplasmin outside the US

FDA extends action date for Bristol-Myers Squibb, Pfizer's Eliquis NDA

FDA extends action date for Bristol-Myers Squibb, Pfizer's Eliquis NDA

WATCHMAN device may prevent stroke in AF patients

WATCHMAN device may prevent stroke in AF patients

FDA assigns Priority Review designation to JRD's XARELTO sNDA

FDA assigns Priority Review designation to JRD's XARELTO sNDA

Combination of key guideline-recommended heart failure therapies improve survival odds

Combination of key guideline-recommended heart failure therapies improve survival odds

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.